Bladder Catheters During Ablation Procedures
Examining the Routine Use of Bladder Catheters During Atrial Fibrillation Procedures
1 other identifier
interventional
160
1 country
1
Brief Summary
Inserting a Bladder catheter during catheter ablation is standard practice at most Institutions. Unfortunately, bladder catheters are associated with adverse outcomes, including catheter associated cystitis, hematuria, dysuria, and urethral damage. The investigator proposes a prospective, randomized clinical trial comparing group A that will receive a catheter during the ablation procedure and group B that will not receive the procedure. The Investigator hypothesizes the group receiving the bladder catheters will have a higher rate of complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2018
CompletedFirst Submitted
Initial submission to the registry
July 27, 2018
CompletedFirst Posted
Study publicly available on registry
August 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2020
CompletedSeptember 30, 2021
September 1, 2021
2 years
July 27, 2018
September 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite of catheter associated complications at day one and thirty will be assessed among the two arms - those with bladder catheters and those who did not receive the bladder catheter during the ablation procedure.
Per patient reported outcomes, subjects will be asked if they experienced any of the following complications: cystitis, hematuria, dysuria, urethral damage and urinary retention. The primary composite outcome of cystitis, hematuria, dysuria, urethral damage or urinary retention will be compared using Chisq or Fisher's exact test. Additional bivariate correlates to the primary outcome will be analysed including age, gender, operator, procedure satisfaction score, procedure duration, procedural fluid administration, total hospital stay fluid administration, and baseline clinical variables. Variables with p value \<o.o5 on bivariate analysis will be included in a multivariate regression model.
Post-op day 1 and 30 days
Study Arms (2)
No Bladder catheter
EXPERIMENTALSubjects will not have bladder catheter inserted during their ablation procedure. Intervention: No catheter
Bladder catheter inserted
ACTIVE COMPARATORBladder catheter will be inserted prior to starting ablation procedure after the subject is under general anesthesia. Intervention: bladder catheter inserted
Interventions
Bladder catheter will be inserted according to randomization schema
Subjects will not receive a bladder catheter during the ablation procedure
Eligibility Criteria
You may qualify if:
- All subjects presenting to the St. Vincent EP lab for AF ablation Ability to sign informed consent
You may not qualify if:
- Recent (within 1 month) cystitis, history of urinary retention or incontinence, prior bladder catheter associated complications, hematuria, chronic kidney disease (stage II, III, IV, or V), dialysis, prostate cancer, renal cancer, bladder cancer, expected procedure duration \>6 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Vincent Hospital and Healthcare Center
Indianapolis, Indiana, 46260, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2018
First Posted
August 17, 2018
Study Start
January 16, 2018
Primary Completion
January 16, 2020
Study Completion
January 16, 2020
Last Updated
September 30, 2021
Record last verified: 2021-09